OM · NASDAQ · Medical - Devices

Outset Medical

Provides the Tablo hemodialysis platform for hospital, clinic, and home care.

$3.91
After-hours close−0.03 (−0.87%)
At close$3.94(−3.67%)

Breakdown13F · Form 4

Institutions 74.70%13.85M sharesInsiders 5.31%984.9K sharesOther 19.99%3.70M shares

Shares outstanding 18.54M · Float 15.50M · 83.6% free float

Top shareholders13F · 13D/G · Form 4

HolderShares% outstandingFormFiled
FMR LLC2.74M14.80%13FAug 13, 2026
BML Capital Management, LLC2.52M13.59%13FAug 7, 2026
BML Investment Partners, L.P.2.52M13.60%13GMay 18, 2026
Leonard Braden Michael · 10 percent owner2.52M13.59%Form 4May 18, 2026
Alyeska Investment Group, L.P.1.70M9.61%13GMay 15, 2025

Institutions13F, as of Jun 30, 2026

95 holders · 13.85M shares · 20 new positions · 51 increased · 28 reduced · 24 closed

HolderShares% outstandingChg q/qFiled
FMR LLC2.74M14.80%+1.2KAug 13, 2026
BML Capital Management, LLC2.52M13.59%+617.5KAug 7, 2026
AQR Capital Management LLC999.0K5.39%+190.7KAug 14, 2026
Perceptive Advisors LLC833.3K4.50%0Aug 14, 2026
Vanguard Capital Management LLC780.1K4.21%+16.3KAug 13, 2026
Bank of America Corp /DE/665.8K3.59%−283.6KAug 14, 2026
PFM Health Sciences, LP582.1K3.14%−12.5KAug 14, 2026
Ensign Peak Advisors, Inc434.3K2.34%−92.2KAug 14, 2026

Beneficial owners13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
FMR LLC14.50%2.60M13GApr 7, 2025
BML Investment Partners, L.P.13.60%2.52M13GMay 18, 2026
Durable Capital Partners LP9.90%13GJan 10, 2025
Alyeska Investment Group, L.P.9.61%1.70M13GMay 15, 2025
Perceptive Advisors LLC9.50%13GFeb 28, 2025
BlackRock, Inc.6.80%1.21M13GOct 17, 2025
Bank of America Corp /DE/5.20%950.6K13GFeb 11, 2026

InsidersForm 4

InsiderRoleShares% outstandingFiled
Leonard Braden Michael10 percent owner2.52M13.59%May 18, 2026
Leslie Triggdirector, officer: Chair and CEO236.3K1.27%Aug 18, 2026
Renee Gaetaofficer: Chief Financial Officer180.8K0.98%Aug 18, 2026
Patrick T. Hackettdirector147.5K0.80%Jun 5, 2026
Derick A. Elliottofficer: EVP, Commercial96.0K0.52%Apr 8, 2026
John L. Brottemofficer: General Counsel87.5K0.47%Aug 18, 2026
Brent D. Langdirector45.2K0.24%Jun 5, 2026
Marc Nashofficer: EVP Operations R&D & Service38.4K0.21%May 19, 2026
D. Keith Grossmandirector37.4K0.20%Jun 5, 2026
Kevin C. Oboyledirector34.8K0.19%Jun 5, 2026

4 ten-percent owners hold 2.83M shares by Form 4, outside the officers-and-directors figure above · 8 people have not refiled in the last 18 months (61.0K shares), so they are not in the figure above

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Aug 17, 2026
Leslie Triggdirector, officer: Chair and CEO
Sale3,437$4.39194,597
Aug 17, 2026
John L. Brottemofficer: General Counsel
Sale2,632$4.3987,475
Aug 17, 2026
Renee Gaetaofficer: Chief Financial Officer
Sale4,543$4.39180,840
Jun 3, 2026
Renee Gaetaofficer: Chief Financial Officer
Sale17,672$4.94113,753
May 15, 2026
John L. Brottemofficer: General Counsel
Sale2,638$3.7030,277
May 15, 2026
Marc Nashofficer: EVP Operations R&D & Service
Sale1,582$3.7038,393
May 15, 2026
Leslie Triggdirector, officer: Chair and CEO
Sale3,445$3.7098,874
Feb 17, 2026
Marc Nashofficer: EVP Operations R&D & Service
Sale1,817$3.3539,988
Feb 17, 2026
Leslie Triggdirector, officer: Chair and CEO
Sale3,361$3.35102,342
Feb 17, 2026
John L. Brottemofficer: General Counsel
Sale2,842$3.3532,935

CongressHouse and Senate disclosures

Not reported.